drugset / Trial / NCT01773096

Methylnaltrexone Use for Opioid-induced Postoperative Constipation

NCT01773096 ↗

Phase 4 Completed 60 enrolled Shriners Hospitals for Children
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.

Timeline

Start
2013-05
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified 0.15 mg/kg —
Subject Methylnaltrexone Other / unclassified 8 mg —
Subject Methylnaltrexone Other / unclassified 12 mg —
Background Bisacodyl Small molecule — —
Background Docusate Sodium Unknown — —
Background Polyethylene Glycol 3350 Other / unclassified — —
Background Senna Traditional medicine (herbal / TCM) — —
Background magnesium hydroxide Unknown — —

Indications